InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Net selling
CIK 0001438533 #1223 in the set updated 22 Sep 2026
Bought (120 mo)
$89.25K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$129.25M
$14.01M on a plan · $99.79M straight out of an exercise
Sold at will
$15.45M
267 of 431 sales
Net
−$129.16M
−$15.36M against sales at will

By person

21 insiders · 433 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
$46.63M (53) scheduled
−$46.63M
432,886
0.4592%
$28.12M
—
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
—
$19.90M (35) scheduled
−$19.90M
117,066
0.1242%
$7.60M
+865.6%
ROTE WILLIAM E.
Chief Research Officer
—
$18.35M (59) scheduled
−$18.35M
98,197
0.1042%
$6.38M
+826.3%
REED ELIZABETH E
Chief Legal Officer and GC
—
$9.27M (70) scheduled
−$9.27M
105,389
0.1118%
$6.85M
+6,088%
ASELAGE STEVE
Director
$89.25K (1)
$7.30M (40) scheduled
−$7.21M
166,419
0.1766%
$10.81M
−50.4%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
$6.30M (30) scheduled
−$6.30M
42,353
0.0449%
$2.75M
+40.5%
Inrig Jula
EVP, Head of R&D & CMO
—
$5.51M (28) scheduled
−$5.51M
100,491
0.1066%
$6.53M
—
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$4.96M (32) scheduled
−$4.96M
87,508
0.0928%
$5.68M
+204.7%
Baynes Roy D.
Director
—
$3.09M (8) scheduled
−$3.09M
41,500
0.0440%
$2.70M
+937.5%
Meckler Jeffrey A
Director
—
$2.27M (6) scheduled
−$2.27M
91,500
0.0971%
$5.94M
+69.4%
Clague Laura
Chief Financial Officer
—
$1.93M (35)
−$1.93M
35,655
0.0378%
$2.32M
—
LYONS GARY A
Director
—
$1.55M (8) scheduled
−$1.55M
61,500
0.0652%
$3.99M
+156.3%
Coughlin Timothy
Director
—
$1.27M (3) scheduled
−$1.27M
56,250
0.0597%
$3.65M
+155.7%
McFarlane Neil F.
Chief Operating Officer
—
$552.56K (7)
−$552.56K
26,988
0.0286%
$1.75M
+56.1%
Rosenberg Noah L.
Chief Medical Officer
—
$366.78K (17)
−$366.78K
47,614
0.0505%
$3.09M
+2,185%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.56M
—
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.56M
—
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.21M
—
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.13M
—
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$1.93M
—
KOZARICH JOHN W
Director
—
—
—
29,000
0.0308%
$1.88M
+31.8%

Individual transactions

67
Insider
Date
Role
Action
Shares
Price
Amount
Coughlin Timothy
15 May 2026
Director
Sold on a plan
3,250
$43.49
$141.34K
Cline Christopher R.
6 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
310
$43.95
$13.62K
Dube Eric M
6 May 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
22,500
$43.95
$988.88K
Inrig Jula
6 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
311
$43.95
$13.67K
REED ELIZABETH E
6 May 2026
Chief Legal Officer and GC
Sold on a plan
2,076
$43.95
$91.24K
ROTE WILLIAM E.
6 May 2026
Chief Research Officer
Sold on a plan
2,763
$43.95
$121.43K
Cline Christopher R.
5 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
2,181
$46.65
$101.74K
Inrig Jula
5 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
2,174
$46.65
$101.42K
REED ELIZABETH E
5 May 2026
Chief Legal Officer and GC
Sold on a plan
2,174
$46.65
$101.42K
ROTE WILLIAM E.
22 Apr 2026
Chief Research Officer
Sold on a plan
9,100
$39.09
$355.72K
Inrig Jula
15 Apr 2026
CHIEF MEDICAL OFFICER
Sold on a plan
1,018
$42.61
$43.38K
Cline Christopher R.
15 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,014
$42.61
$43.21K
REED ELIZABETH E
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
1,559
$42.53
$66.30K
REED ELIZABETH E
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
5,226
$41.62
$217.51K
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
20
$42.66
$853.20
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
7,165
$41.75
$299.14K
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
56,815
$41.01
$2.33M
Inrig Jula
14 Apr 2026
CHIEF MEDICAL OFFICER
Sold on a plan
7,215
$41.93
$302.52K
Cline Christopher R.
14 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
7,239
$41.93
$303.52K
Cline Christopher R.
14 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
9
$41.07
$369.63
Cline Christopher R.
13 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
65
$28.85
$1.88K
REED ELIZABETH E
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
509
$32.74
$16.66K
REED ELIZABETH E
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
2,485
$32.07
$79.69K
Cline Christopher R.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
110
$32.90
$3.62K
Cline Christopher R.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,635
$32.14
$52.55K
Inrig Jula
4 Feb 2026
CHIEF MEDICAL OFFICER
Sold on a plan
232
$32.85
$7.62K
Inrig Jula
4 Feb 2026
CHIEF MEDICAL OFFICER
Sold on a plan
1,547
$32.11
$49.67K
ROTE WILLIAM E.
3 Feb 2026
Chief Research Officer
Sold on a plan
12,446
$32.87
$409.10K
Dube Eric M
3 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
33,635
$32.70
$1.10M
Dube Eric M
3 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
66,452
$32.06
$2.13M
Inrig Jula
6 Jan 2026
CHIEF MEDICAL OFFICER
Sold on a plan
445
$37.75
$16.80K
Inrig Jula
5 Jan 2026
CHIEF MEDICAL OFFICER
Sold on a plan
2,031
$40.18
$81.61K
Calvin Sandra
24 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
7,402
$40.00
$296.08K
Heerma Peter
24 Dec 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
4,980
$40.00
$199.20K
Calvin Sandra
15 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
2,910
$36.00
$104.76K
Heerma Peter
31 Oct 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
5,591
$35.00
$195.69K
Heerma Peter
28 Oct 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
2,662
$30.00
$79.86K
Cline Christopher R.
4 Sep 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
119
$19.71
$2.35K
Cline Christopher R.
3 Sep 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
454
$18.20
$8.26K
Cline Christopher R.
27 Aug 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
470
$17.31
$8.14K
Inrig Jula
1 Jul 2025
CHIEF MEDICAL OFFICER
Sold on a plan
815
$14.65
$11.94K
REED ELIZABETH E
5 May 2025
Chief Legal Officer and GC
Sold on a plan
4,920
$21.05
$103.57K
ROTE WILLIAM E.
5 May 2025
Chief Research Officer
Sold on a plan
3,198
$21.05
$67.32K
Dube Eric M
5 May 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
18,924
$21.05
$398.35K
Heerma Peter
12 Feb 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
2,568
$23.53
$60.43K
REED ELIZABETH E
12 Feb 2025
SVP, GC & CORPORATE SECRETARY
Sold on a plan
8,000
$23.53
$188.24K
ROTE WILLIAM E.
12 Feb 2025
SENIOR VICE PRESIDENT, R&D
Sold on a plan
5,200
$23.53
$122.36K
Dube Eric M
11 Feb 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
11,375
$24.04
$273.46K
Heerma Peter
11 Feb 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
3,074
$25.00
$76.85K
Inrig Jula
4 Feb 2025
CHIEF MEDICAL OFFICER
Sold on a plan
1,066
$20.11
$21.44K
Inrig Jula
3 Feb 2025
CHIEF MEDICAL OFFICER
Sold on a plan
4,207
$20.12
$84.64K
Dube Eric M
3 Feb 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
50,691
$20.21
$1.02M
REED ELIZABETH E
3 Feb 2025
SVP, GC & CORPORATE SECRETARY
Sold on a plan
8,951
$19.78
$177.05K
ROTE WILLIAM E.
3 Feb 2025
SENIOR VICE PRESIDENT, R&D
Sold on a plan
8,951
$19.78
$177.05K
REED ELIZABETH E
22 Jan 2025
SVP, GC & CORPORATE SECRETARY
Sold on a plan
2,437
$19.46
$47.42K
Dube Eric M
22 Jan 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
10,736
$19.46
$208.92K
ROTE WILLIAM E.
22 Jan 2025
SENIOR VICE PRESIDENT, R&D
Sold on a plan
2,437
$19.46
$47.42K
Inrig Jula
6 Jan 2025
CHIEF MEDICAL OFFICER
Sold on a plan
440
$18.76
$8.25K
Inrig Jula
3 Jan 2025
CHIEF MEDICAL OFFICER
Sold on a plan
2,066
$19.10
$39.46K
Inrig Jula
10 Sep 2024
CHIEF MEDICAL OFFICER
Sold on a plan
684
$12.98
$8.88K
Dube Eric M
9 Sep 2024
CHIEF EXECUTIVE OFFICER
Sold on a plan
21,125
$11.52
$243.36K
REED ELIZABETH E
9 Sep 2024
SVP, GC & CORPORATE SECRETARY
Sold on a plan
4,387
$11.52
$50.54K
ROTE WILLIAM E.
9 Sep 2024
SENIOR VICE PRESIDENT, R&D
Sold on a plan
4,387
$11.52
$50.54K
Calvin Sandra
11 May 2023
SVP, Chief Accounting Officer
Sold on a plan
122
$16.12
$1.97K
Calvin Sandra
10 May 2023
SVP, Chief Accounting Officer
Sold on a plan
436
$16.59
$7.23K
ROTE WILLIAM E.
10 May 2023
Senior Vice President, R&D
Sold on a plan
825
$16.59
$13.69K
REED ELIZABETH E
10 May 2023
SVP, GC & Corporate Secretary
Sold on a plan
825
$16.59
$13.69K
Showing 250 of 433 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 423
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 97
Sales at will 267
Transactions with no price 0
Shares from compensation/vesting 4,655,938
Sales filed before the plan box existed 219
History held since 2 Sep 2016